Wait Times From Cancer Diagnosis to First Treatment Longer, Negative Impact on Survival
Data from the National Cancer Database are indicating that wait times from cancer diagnosis to initial treatment were substantially longer over a 5-year period.
Diagnosis & Disease Information
Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
Adding a second HER2-blocker to standard care therapy after surgery for HER2-positive breast cancer may be modestly beneficial for some women.
Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
Phase 3 clinical trial results show fewer adverse effects and longer survival with alectinib compared with crizotinib in patients with treatment-naïve ALK-positive NSCLC.
Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.
ASCO: CAR T-Cell Therapy Promising for Multiple Myeloma
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein demonstrated promising results.
Older Patients Under-Represented in Cancer Drug Clinical Trials
Older adults are underrepresented in clinical trials of cancer drugs, according to study findings presented at the 2017 ASCO Annual Meeting.
Self-Reports on Adverse Effects From Younger Patients Are Reliable, Accurate
Children and adolescent patients with cancer are able to accurately report subjective adverse events (AEs) they experience during their cancer treatment, and they are willing to do so.
Checkpoint Inhibitors Appear Safe for Pediatric Cancer Patients
The medications so far show little efficacy in children with cancer, but new studies may provide clues to how to change this, pediatric oncologist says.
Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC
Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.
Ovarian Function Recovery May Increase Risk of Breast Cancer Recurrence
Ovarian function recovery (OFR) in women with chemotherapy-induced ovarian function failure decreases residual 5-year disease-free and overall survival.
- Loading...
Loading...
Next post in ASCO 2017
Loading... 
Loading...